Provides public access to epinephrine auto-injector devices at schools

This bill requires all New York schools - including public, charter, and non-public elementary and secondary schools - to maintain and properly test epinephrine auto-injectors for emergency use during severe allergic reactions. It designates school districts and schools as "public access epinephrine auto-injector device providers" under public health law, mandating they post clear signs showing device locations, notify regional health councils of device locations, and follow manufacturer and government maintenance standards. The law directly affects students, staff, and visitors at all covered schools by ensuring immediate access to life-saving treatment during allergic emergencies. The policy takes effect 90 days after enactment, with no cost or funding mechanisms specified in the bill text.